/Dr. Vasiliki Kalodimou
Characterization of mesenchymal stem cells (MSCs) and their use in the treatment of COVID-19
Characterization of mesenchymal stem cells (MSCs) and their use in the treatment of COVID-19
29 Sept 2021

Watch this presentation by Dr. Vasiliki E. Kalodimou, IASO Maternity-Pediatric and Research Hospital, titled: Characterization of mesenchymal stem cells (MSCs) and their use in the treatment of COVID-19. This keynote talk was presented at the SelectScience® Virtual Clinical Science Summit 2021.